Turcotte, Anne-Frédérique
Grenier-Larouche, Thomas
Lacombe, Julie
Carreau, Anne-Marie
Carpentier, André C.
Mac-Way, Fabrice
Tchernof, André
Richard, Denis
Biertho, Laurent
Lebel, Stefane
Marceau, Simon
Ferron, Mathieu
Gagnon, Claudia
Funding for this research was provided by:
Canadian Diabetes Association (NC-3-17-5232-CG)
Article History
Received: 7 February 2020
Accepted: 4 May 2020
First Online: 17 May 2020
Compliance with ethical standards
:
: A.M.C. receives consultation honoraria from Pfizer. A.C.C. is the recipient of the Canada Research Chair in Molecular Imaging of Diabetes. A.T. and L.B. receive funding from Johnson Johnson Medical Companies and Medtronic for research studies on bariatric surgery. M.F. receives royalties from BioLegend for the development of the ucOCN ELISA assay. T.G.L. is now a full-time employee of Boehringer Ingelheim Canada. F.M. received speaker honoraria from Amgen and Sanofi, and participated in advisory committee for Otsuka. C.G. received research funding from Shire and speaker honoraria from Amgen, Eli Lilly and Janssen.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institut Universitaire de cardiologie et de pneumologie de Québec (IUCPQ) ethical review board.
: Informed consent was obtained for all participants before entering the study.